Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariana Castells

Showing results (131-140 of 176) with videos related to

Pageof 18
Sort By:
Allergy|September 29, 2021
Hypersensitivity reactions to chemotherapy: an EAACI Position PaperMauro Pagani, Sevim Bavbek, Emilio Alvarez-Cuesta, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 24, 2025
Continued symptom and quality of life improvement with favorable safety shown with long-term avapritinib in indolent systemic mastocytosisMariana Castells, Cem Akin, Karin Hartmann, et al.
The Journal of Allergy and Clinical Immunology|November 28, 2020
Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphologyMatthew P Giannetti, Cem Akin, Raied Hufdhi, et al.
The World Allergy Organization Journal|December 27, 2012
A world allergy organization international survey on diagnostic procedures and therapies in drug allergy/hypersensitivityBernard Yu-Hor Thong, Rita Mirakian, Mariana Castells, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 28, 2022
Network autonomic analysis of post-acute sequelae of COVID-19 and postural tachycardia syndromePeter Novak, Matthew P Giannetti, Emily Weller, et al.
Clinical Reviews in Allergy & Immunology|August 17, 2023
Hypersensitivity Reactions to Taxanes: A Comprehensive and Systematic Review of the Efficacy and Safety of DesensitizationRosalaura Virginia Villarreal-González, Sandra González-Díaz, Oscar Vidal-Gutiérrez, et al.
Journal of Clinical Immunology|May 16, 2017
Deficiency of Interleukin-1 Receptor Antagonist (DIRA): Report of the First Indian Patient and a Novel Deletion Affecting IL1RNLeonardo O Mendonca, Louise Malle, Frank X Donovan, et al.
Allergy|January 19, 2026
Development of Betalactam-Predictor: A Clinical Decision Tool for Delabeling Low-Risk Betalactam Allergy Patients. Initial Validation in Penicillin AllergyMarina Labella, Rafael Nuñez, Inmaculada Doña, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 25, 2021
COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptomsMatthew P Giannetti, Emily Weller, Iván Alvarez-Twose, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2023
Multistep IgE Mast Cell Desensitization Is a Dose- and Time-Dependent Process Partially Regulated by SHIP-1Ather Adnan, Shree Acharya, Leila A Alenazy, et al.
Pageof 18

Showing results (131-140 of 176) with videos related to

Sort By:
Pageof 18
Allergy|September 29, 2021
Hypersensitivity reactions to chemotherapy: an EAACI Position PaperMauro Pagani, Sevim Bavbek, Emilio Alvarez-Cuesta, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 24, 2025
Continued symptom and quality of life improvement with favorable safety shown with long-term avapritinib in indolent systemic mastocytosisMariana Castells, Cem Akin, Karin Hartmann, et al.
The Journal of Allergy and Clinical Immunology|November 28, 2020
Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphologyMatthew P Giannetti, Cem Akin, Raied Hufdhi, et al.
The World Allergy Organization Journal|December 27, 2012
A world allergy organization international survey on diagnostic procedures and therapies in drug allergy/hypersensitivityBernard Yu-Hor Thong, Rita Mirakian, Mariana Castells, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 28, 2022
Network autonomic analysis of post-acute sequelae of COVID-19 and postural tachycardia syndromePeter Novak, Matthew P Giannetti, Emily Weller, et al.
Clinical Reviews in Allergy & Immunology|August 17, 2023
Hypersensitivity Reactions to Taxanes: A Comprehensive and Systematic Review of the Efficacy and Safety of DesensitizationRosalaura Virginia Villarreal-González, Sandra González-Díaz, Oscar Vidal-Gutiérrez, et al.
Journal of Clinical Immunology|May 16, 2017
Deficiency of Interleukin-1 Receptor Antagonist (DIRA): Report of the First Indian Patient and a Novel Deletion Affecting IL1RNLeonardo O Mendonca, Louise Malle, Frank X Donovan, et al.
Allergy|January 19, 2026
Development of Betalactam-Predictor: A Clinical Decision Tool for Delabeling Low-Risk Betalactam Allergy Patients. Initial Validation in Penicillin AllergyMarina Labella, Rafael Nuñez, Inmaculada Doña, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 25, 2021
COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptomsMatthew P Giannetti, Emily Weller, Iván Alvarez-Twose, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2023
Multistep IgE Mast Cell Desensitization Is a Dose- and Time-Dependent Process Partially Regulated by SHIP-1Ather Adnan, Shree Acharya, Leila A Alenazy, et al.
Pageof 18